{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:16:19Z","timestamp":1792264579128,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK59615"],"award-info":[{"award-number":["R01 DK59615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA21171"],"award-info":[{"award-number":["R01 AA21171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008318","name":"Spanish Association for the Study of the Liver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.jcmgh.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:35:48Z","timestamp":1537058148000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-\u03b2 Dependent Hepatic Stellate Cell Activation and Liver Fibrosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Rosa","family":"Martin-Mateos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago M.","family":"De Assuncao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Jalan-Sakrikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas K.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Mathison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Lomberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Huebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib2","first-page":"G605","article-title":"Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury","volume":"304","author":"Perepelyuk","year":"2013","journal-title":"Am J Physiol Liver Physiol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.ajpath.2017.06.009","article-title":"Platelet-derived growth factor receptor \u03b1 contributes to human hepatic stellate cell proliferation and migration","volume":"187","author":"Kikuchi","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and liver fibrosis","volume":"4","author":"Moran-Salvador","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/CCO.0000000000000390","article-title":"Targeting EZH2 in cancer therapy","volume":"29","author":"Yamagishi","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25679","article-title":"Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis","volume":"56","author":"Au","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"e12915","DOI":"10.14814\/phy2.12915","article-title":"EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis","volume":"4","author":"Xiao","year":"2016","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1681\/ASN.2015040457","article-title":"Enhancer of zeste homolog 2 inhibition attenuates renal fibrosis by maintaining Smad7 and phosphatase and tensin homolog expression","volume":"27","author":"Zhou","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"s1109","DOI":"10.1016\/S0016-5085(18)33687-4","article-title":"Transcriptional dysregulation of inflammatory gene networks in alcoholic hepatitis is associated with genomewide reconfiguration of epigenetic states","volume":"154","author":"Arab","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal\u00a0center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib16","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Zingg","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib18","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.humpath.2011.12.004","article-title":"Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer","volume":"43","author":"Hussein","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"e26218","DOI":"10.1002\/pbc.26218","article-title":"Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the pediatric preclinical testing program","volume":"64","author":"Kurmasheva","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"s15","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS11071","article-title":"A\u00a0phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed\/refractory synovial sarcoma","volume":"34","author":"Agulnik","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1101\/gr.108803.110","article-title":"Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer","volume":"21","author":"Matsumura","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype","volume":"23","author":"Watson","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jcb.23457","article-title":"MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells","volume":"113","author":"Li","year":"2012","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"28465","DOI":"10.1074\/jbc.M114.634311","article-title":"Procollagen lysyl hydroxylase 2 expression is regulated by an alternative downstream transforming growth factor \u03b2-1 activation mechanism","volume":"290","author":"Gjaltema","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbagrm.2015.07.013","article-title":"MKL1 is an epigenetic modulator of TGF-\u03b2 induced fibrogenesis","volume":"1849","author":"Fan","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/23808993.2017.1284557","article-title":"The role of epigenomics in personalized medicine","volume":"2","author":"Kronfol","year":"2017","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","article-title":"A\u00a0proof-of-concept for epigenetic therapy of tissue fibrosis: inhibition of liver fibrosis progression by 3-deazaneplanocin A","volume":"25","author":"Zeybel","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/jcmm.13153","article-title":"EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis","volume":"21","author":"Yang","year":"2017","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","article-title":"Beta-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/beta-catenin signaling inhibits hepatic stellate cell activation","volume":"9","author":"Ge","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.phrs.2017.10.013","article-title":"Carnosol-mediated sirtuin 1 activation inhibits enhancer of zeste homolog 2 to attenuate liver fibrosis","volume":"128","author":"Zhao","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/hep.23931","article-title":"E-cadherin antagonizes transforming growth factor \u03b21 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation","volume":"52","author":"Cho","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-018-0670-2","article-title":"Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2014.05.015","article-title":"The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma","volume":"61","author":"Gao","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3125","article-title":"The methyltransferase EZH2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin","volume":"16","author":"Gunawan","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein EZH2 controls actin polymerization and cell signaling","volume":"121","author":"Su","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.15252\/embr.201643237","article-title":"A\u00a0non-canonical function of EZH2 preserves immune homeostasis","volume":"18","author":"Vasanthakumar","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2016-01-690701","article-title":"EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer\/T-cell lymphoma","volume":"128","author":"Yan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"e0165005","DOI":"10.1371\/journal.pone.0165005","article-title":"Non-canonical EZH2 transcriptionally activates RelB in triple negative breast cancer","volume":"11","author":"Lawrence","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13238-013-2093-2","article-title":"EZH2, an epigenetic driver of prostate cancer","volume":"4","author":"Yang","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijbs.8.59","article-title":"EZH2 methyltransferase and H3K27 methylation in breast cancer","volume":"8","author":"Yoo","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib42","doi-asserted-by":"crossref","first-page":"37974","DOI":"10.18632\/oncotarget.16467","article-title":"Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target","volume":"8","author":"Wen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib43","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/pmic.200700019","article-title":"Proteomic\u00a0analysis of EZH2 downstream target proteins\u00a0in\u00a0hepatocellular carcinoma","volume":"7","author":"Chen","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-017-0670-6","article-title":"EZH2 promotes hepatocellular carcinoma progression through modulating miR-22\/galectin-9 axis","volume":"37","author":"Chen","year":"2018","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib45","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.3892\/mmr.2017.7828","article-title":"MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2","volume":"16","author":"Cui","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopha.2016.11.035","article-title":"Overexpression of the long\u00a0non-coding RNA SPRY4-IT1 promotes tumor cell\u00a0proliferation and invasion by activating EZH2 in hepatocellular carcinoma","volume":"85","author":"Zhou","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib47","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jhep.2014.11.040","article-title":"A\u00a0CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients","volume":"62","author":"Feng","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib48","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjc.6602531","article-title":"Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma","volume":"92","author":"Sudo","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib49","doi-asserted-by":"crossref","first-page":"E3509","DOI":"10.1073\/pnas.1802691115","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells","volume":"115","author":"Bugide","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib50","doi-asserted-by":"crossref","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28921","article-title":"The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice","volume":"65","author":"Maiers","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-8935-6-3","article-title":"Functional characterization of EZH2\u03b2 reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression","volume":"6","author":"Grzenda","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib53","doi-asserted-by":"crossref","first-page":"G819","DOI":"10.1152\/ajpgi.00041.2014","article-title":"Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges","volume":"306","author":"Mathews","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2018.09.005_bib54","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","volume":"96","author":"Tag","year":"2015","journal-title":"J\u00a0Vis Exp"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:20:01Z","timestamp":1762453201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X18301279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["S2352345X18301279"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.005","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-\u03b2 Dependent Hepatic Stellate Cell Activation and Liver Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}